QSAR and Docking Studies on Different Series of Histone Deacetylase Inhibitors (HDACIs)

Publisher： Bentham Science Publishers

E-ISSN： 1875-628x|9|4|367-378

ISSN： 1570-1808

Source： Letters in Drug Design & Discovery, Vol.9, Iss.4, 2012-05, pp. : 367-378

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

3D QSAR of Aminophenyl Benzamide Derivatives as Histone Deacetylase Inhibitors

By  

Medicinal Chemistry, Vol. 6, Iss. 5, 2010-09 ,pp. : 277-285

Bentham Science Publishers

Access to resources Recommend Favorite

QSAR and Molecular Docking Studies on a Series of Cinnamic Acid Analogues as Epidermal Growth Factor Receptor (EGFR) Inhibitors

By  

Letters in Drug Design & Discovery, Vol. 14, Iss. 1, 2017-01 ,pp. : 83-95

Bentham Science Publishers

Access to resources Recommend Favorite

3D-QSAR and Docking Studies on a Series of Benzothiadiazine Derivatives as Genotype 1 HCV Polymerase Inhibitors

By  

Medicinal Chemistry, Vol. 8, Iss. 6, 2012-11 ,pp. : 1099-1107

Bentham Science Publishers

Access to resources Recommend Favorite

Computational Studies on the Histone Deacetylases and the Design of Selective Histone Deacetylase Inhibitors

By  

Current Topics in Medicinal Chemistry, Vol. 9, Iss. 3, 2009-02 ,pp. : 241-256

Bentham Science Publishers

Access to resources Recommend Favorite

Histone deacetylase inhibitors

By Price Steve   Dyke Hazel J  

Expert Opinion on Therapeutic Patents, Vol. 17, Iss. 7, 2007-07 ,pp. : 745-765

Informa Healthcare

Access to resources Recommend Favorite